Advanced search
Publication Cover
Acta Cardiologica Volume 78, 2023 - Issue 5
Submit an article Journal homepage
1,494
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Focus on cardiometabolic risk factors

Patrizio Lancellottia Department of Cardiology, CHU SartTilman, University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium;b Maria Cecilia Hospital, Cotignola, and Anthea Hospital, Gruppo Villa Maria Care and Research, Bari, ItalyCorrespondence[email protected]
Pages 515-518 | Published online: 17 Jul 2023

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Patrizio Lancellotti. (2024) Acute and chronic coronary artery disease. Acta Cardiologica 79:2, pages 105-108.
Read now
Patrizio Lancellotti & Alain Nchimi. (2024) Bridging perspectives from prevention, diagnosis, management to economic aspects: the voice of Belgian cardiologists. Acta Cardiologica 79:1, pages 1-4.
Read now
Patrizio Lancellotti & Alain Nchimi. (2023) New approaches to cardiovascular diseases. Acta Cardiologica 78:9, pages 977-979.
Read now

Articles from other publishers (1)

Ignacio Ramírez Gallegos, Marta Marina Arroyo, Ángel Arturo López-González, Maria Teófila Vicente-Herrero, Daniela Vallejos, Tomás Sastre-Alzamora & José Ignacio Ramírez-Manent. (2024) The Effect of a Program to Improve Adherence to the Mediterranean Diet on Cardiometabolic Parameters in 7034 Spanish Workers. Nutrients 16:7, pages 1082.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.